BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG)

Historical Holders from Q3 2023 to Q3 2025

Type / Class
Equity / Common Stock, no par value
Symbol
DRUG on Nasdaq
Shares outstanding
7,096,625
Price per share
$60.66
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
6,034,640
Total reported value
$365,700,278
% of total 13F portfolios
0%
Share change
+790,649
Value change
+$48,443,326
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
62
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 16% +1.9% $28,423,825 +$850,785 1,145,660 +3.1% JANUS HENDERSON GROUP PLC 30 Jun 2025
COMMODORE CAPITAL LP 7.2% $15,445,000 500,000 COMMODORE CAPITAL LP 31 Dec 2024
Vivo Opportunity Fund Holdings, L.P. 6.4% $27,550,801 454,184 Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
PERCEPTIVE ADVISORS LLC 6.3% $13,735,208 444,649 Perceptive Advisors LLC 31 Mar 2025
Adage Capital Management, L.P. 5.6% $24,005,770 395,743 Adage Capital Management, L.P. 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P. 2.9% $6,376,530 206,427 RA Capital Management, L.P. 31 Mar 2025
Sio Capital Management, LLC 2.7% -65% $11,571,744 -$19,506,679 190,764 -63% Sio Capital Management, LLC 30 Sep 2025
Point72 Asset Management, L.P. 3% $4,175,988 135,189 Point72 Asset Management, L.P. 31 Dec 2024
As of 30 Sep 2025, BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG) has 62 institutional shareholders filing 13F forms. They hold 6,034,640 shares. of 7,096,625 outstanding shares (85%) .

Top 25 institutional shareholders own 83% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
JANUS HENDERSON GROUP PLC 16% 1,145,660 0% 0.03% $69,134,853
Cormorant Asset Management, LP 15% 1,059,331 0% 4.4% $64,259,018
Vivo Capital, LLC 7.1% 501,617 +99% 2.4% $30,428,087
Commodore Capital LP 7% 500,000 0% 1.5% $30,330,000
PERCEPTIVE ADVISORS LLC 6.3% 449,290 +6.8% 0.8% $27,253,931
ADAGE CAPITAL PARTNERS GP, L.L.C. 5.6% 395,743 +98% 0.04% $24,005,770
BRAIDWELL LP 4.3% 303,685 0.55% $18,421,532
BlackRock, Inc. 3.3% 234,118 +12% 0% $14,201,598
MORGAN STANLEY 2.7% 192,866 +19% 0% $11,699,251
Sio Capital Management, LLC 2.7% 190,764 -63% 2.9% $11,571,744
Balyasny Asset Management L.P. 2.6% 186,922 0.02% $11,338,689
Point72 Asset Management, L.P. 1.5% 105,020 -22% 0.01% $6,370,513
ACUTA CAPITAL PARTNERS, LLC 1.2% 84,875 +75% 5.3% $5,148,518
MILLENNIUM MANAGEMENT LLC 1.1% 76,681 -31% 0% $4,651,469
Walleye Capital LLC 1% 72,754 +36% 0.04% $4,413,258
STATE STREET CORP 0.96% 68,388 +177% 0% $4,148,416
Schonfeld Strategic Advisors LLC 0.94% 66,606 -3.5% 0.03% $4,040,317
GEODE CAPITAL MANAGEMENT, LLC 0.82% 57,899 +0.66% 0% $3,512,152
SUPERSTRING CAPITAL MANAGEMENT LP 0.76% 53,950 3.2% $3,272,607
VANGUARD GROUP INC 0.64% 45,103 +41% 0% $2,735,947
PLATINUM INVESTMENT MANAGEMENT LTD 0.4% 28,308 0% 0.11% $1,717,163
BOOTHBAY FUND MANAGEMENT, LLC 0.4% 28,119 +47% 0.04% $1,705,699
NORTHERN TRUST CORP 0.38% 27,213 +6.2% 0% $1,650,741
JANE STREET GROUP, LLC 0.22% 15,903 0% $964,676
Ikarian Capital, LLC 0.22% 15,431 -76% 0.21% $936,044

Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 6,034,640 $365,700,278 +$48,443,326 6,066% 62
2025 Q2 5,234,387 $136,973,710 -$2,453,899 2,611% 46
2025 Q1 5,217,399 $188,361,504 +$11,625,261 3,607% 34
2024 Q4 4,897,032 $176,406,965 +$167,324,812 3,602% 31
2024 Q3 191,547 $229,810 -$6,160 117% 6
2024 Q2 197,030 $207,191 -$19,280 105% 5
2024 Q1 213,375 $255,563 -$27,190 120% 7
2023 Q4 228,082 $329,806 +$48,212 142.93% 7
2023 Q3 194,505 $309,171 +$309,171 160% 5